Kate E. R. Hollinshead
发表
K. E. Hollinshead,
Kate E. R. Hollinshead,
2017
.
K. Eales,
K. E. Hollinshead,
D. Tennant,
2016,
Oncogenesis.
Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer.
S. Gygi,
D. Bar-Sagi,
J. Paulo,
2020,
Cancer discovery.
C. Ludwig,
I. Tomlinson,
Y. Mao,
2018,
Cell reports.
K. E. Hollinshead,
D. Tennant,
Kate E. R. Hollinshead,
2016,
Wiley interdisciplinary reviews. Systems biology and medicine.
R. Satija,
D. Littman,
A. Kimmelman,
2019,
Cell.
G. Cagney,
A. Letai,
M. Hemann,
2021,
Science Advances.
A. Kimmelman,
K. E. Hollinshead,
M. Philips,
2021,
Nature Communications.
J. Mancias,
M. Cammer,
A. Kimmelman,
2020,
Cell reports.
K. Manolopoulos,
A. Gimenez-Roqueplo,
J. Favier,
2002
.
R. Satija,
D. Littman,
A. Kimmelman,
2019,
Cell.
Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer
Mousheng Xu,
Kwok-Kin Wong,
J. Qi,
2020,
Cancer Research.
Christian M. Metallo,
C. Ludwig,
A. Gimenez-Roqueplo,
2015,
Nature Communications.
A. Gimenez-Roqueplo,
J. Favier,
D. Tennant,
2015
.
C. Ludwig,
K. E. Hollinshead,
D. Tennant,
2016,
Advances in experimental medicine and biology.
Christian M. Metallo,
C. Ludwig,
A. Morin,
2015,
Nature Communications.
K. Hollinshead,
Kate E. R. Hollinshead,
Daniel A. Tennant,
2016
.